Zobrazeno 1 - 10
of 17
pro vyhledávání: '"P. W. G. Van Der Linden"'
Autor:
Eveline P. Mauser-Bunschoten, J. G. van der Bom, G. Goverde, B. A. P. Laros-van Gorkom, H. C. J. Eikenboom, Karin Fijnvandraat, Karina Meijer, E. M. De Wee, Dingeman C. Rijken, Frank W.G. Leebeek, P. W. G. Van Der Linden, K. Klaij
Publikováno v:
Haemophilia. 18:444-451
Patients with von Willebrand disease (VWD), the most common inherited bleeding disorder, display large variation in bleeding tendency, which is not completely related to VWF levels. The cause of variability in clinical expression is largely unknown.
Autor:
Irena Novakova, Paula F. Ypma, Paul F.W. Strengers, P. W. G. Van Der Linden, Mmw Koopman, I. Kleine Budde, Evelien P. Mauser-Bunschoten, Jerzy Windyga, S. Lopaciuk, F. J. M. Van Der Meer
Publikováno v:
Haemophilia. 17:439-445
Nonafact(®), an ultrapure, monoclonal antibody-purified factor IX concentrate (FIX) was developed to minimize risk of thrombotic complications and viral transmission. To investigate the pharmacokinetics, efficacy and safety, phase III/IV studies wer
Autor:
G. M. Van Marwijk Kooij, Mmw Koopman, J van der Meer, F. W. G. Leebeek, Arja de Goede-Bolder, P. W. G. Van Der Linden, Evelien P. Mauser-Bunschoten
Publikováno v:
Haemophilia. 8:649-656
We have prospectively monitored treatment of haemophilia patients with inhibitors by recombinant factor VIIa (rFVIIa) administered by continuous infusion to obtain more insight in the underlying factors of the clinical efficacy of this administration
Publikováno v:
Journal of Allergy and Clinical Immunology. 100:767-770
Background: Venom immunotherapy is effective in preventing systemic reactions in patients with a history of an anaphylactic reaction to Hymenoptera stings. It is uncertain how long venom immunotherapy should be continued. Objective: We evaluated whet
Autor:
M M, Smits, P W G, van der Linden
Publikováno v:
The Netherlands journal of medicine. 70(4)
Autor:
E M, De Wee, K, Klaij, H C J, Eikenboom, J G, Van Der Bom, K, Fijnvandraat, B A P, Laros-Van Gorkom, E P, Mauser-Bunschoten, K, Meijer, G, Goverde, P W G, Van Der Linden, D C, Rijken, F W G, Leebeek
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(3)
Patients with von Willebrand disease (VWD), the most common inherited bleeding disorder, display large variation in bleeding tendency, which is not completely related to VWF levels. The cause of variability in clinical expression is largely unknown.
Autor:
E P, Mauser-Bunschoten, I, Kleine Budde, S, Lopaciuk, M M W, Koopman, F J M, Van Der Meer, I R O, Novàkovà, P, Ypma, P W G, Van Der Linden, J, Windyga, P F W, Strengers
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(3)
Nonafact(®), an ultrapure, monoclonal antibody-purified factor IX concentrate (FIX) was developed to minimize risk of thrombotic complications and viral transmission. To investigate the pharmacokinetics, efficacy and safety, phase III/IV studies wer
Publikováno v:
Blood. 82:1732-1739
A postulated role of the contact system in anaphylactic reactions to insect stings was investigated. During prospective, in-hospital sting challenge, we collected serial blood samples from five normal volunteers and 16 patients with a history of inse
Autor:
Dorina Roem, J. K. Van Der Zwan, P.-W. G. Van Der Linden, Mieke C. Brouwer, C. E. Hack, A. Struyvenberg, J. P. De Boer
Publikováno v:
Blood. 82:1740-1748
The pathogenesis of anaphylactic shock is not completely understood. Mast cell degranulation products may stimulate endothelial cells, leading to activation of fibrinolytic and coagulation systems. We investigated the activation of these systems in i
Autor:
A. Struyvenberg, J. K. Van Der Zwan, Y. C. Vivie-Kipp, C. E. Hack, J. Poortman, P.-W. G. Van Der Linden
Publikováno v:
Journal of Allergy and Clinical Immunology. 90:110-118
One hundred thirty-eight patients with a previous anaphylactic reaction to a yellow jacket or a honeybee sting, as well as eight volunteers, were subjected to an in-hospital sting challenge. Plasma levels of histamine, tryptase, and prostaglandin D 2